125 related articles for article (PubMed ID: 38326602)
1. Discovery of novel DNA methylation biomarker panels for the diagnosis and differentiation between common adenocarcinomas and their liver metastases.
Draškovič T; Hauptman N
Sci Rep; 2024 Feb; 14(1):3095. PubMed ID: 38326602
[TBL] [Abstract][Full Text] [Related]
2. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
Brown ZJ; Hewitt DB; Pawlik TM
Front Biosci (Landmark Ed); 2022 Mar; 27(3):85. PubMed ID: 35345317
[TBL] [Abstract][Full Text] [Related]
6. "OMICS" technologies and their role in foregut primary malignancies.
Farid SG; Morris-Stiff G
Curr Probl Surg; 2015 Oct; 52(10):409-41. PubMed ID: 26527526
[No Abstract] [Full Text] [Related]
7. DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours.
Dragomir MP; Calina TG; Perez E; Schallenberg S; Chen M; Albrecht T; Koch I; Wolkenstein P; Goeppert B; Roessler S; Calin GA; Sers C; Horst D; Roßner F; Capper D
EBioMedicine; 2023 Jul; 93():104657. PubMed ID: 37348162
[TBL] [Abstract][Full Text] [Related]
8. Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors.
Draškovič T; Zidar N; Hauptman N
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765815
[TBL] [Abstract][Full Text] [Related]
9. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis.
Garcia-Recio S; Hinoue T; Wheeler GL; Kelly BJ; Garrido-Castro AC; Pascual T; De Cubas AA; Xia Y; Felsheim BM; McClure MB; Rajkovic A; Karaesmen E; Smith MA; Fan C; Ericsson PIG; Sanders ME; Creighton CJ; Bowen J; Leraas K; Burns RT; Coppens S; Wheless A; Rezk S; Garrett AL; Parker JS; Foy KK; Shen H; Park BH; Krop I; Anders C; Gastier-Foster J; Rimawi MF; Nanda R; Lin NU; Isaacs C; Marcom PK; Storniolo AM; Couch FJ; Chandran U; Davis M; Silverstein J; Ropelewski A; Liu MC; Hilsenbeck SG; Norton L; Richardson AL; Symmans WF; Wolff AC; Davidson NE; Carey LA; Lee AV; Balko JM; Hoadley KA; Laird PW; Mardis ER; King TA; ; Perou CM
Nat Cancer; 2023 Jan; 4(1):128-147. PubMed ID: 36585450
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma.
Liang W; Xu Z; Kong F; Huang X; Xiao Y; Zhou W; Ye S; Ye Q
Front Genet; 2022; 13():1065693. PubMed ID: 36479252
[No Abstract] [Full Text] [Related]
11. Ensembl 2023.
Martin FJ; Amode MR; Aneja A; Austine-Orimoloye O; Azov AG; Barnes I; Becker A; Bennett R; Berry A; Bhai J; Bhurji SK; Bignell A; Boddu S; Branco Lins PR; Brooks L; Ramaraju SB; Charkhchi M; Cockburn A; Da Rin Fiorretto L; Davidson C; Dodiya K; Donaldson S; El Houdaigui B; El Naboulsi T; Fatima R; Giron CG; Genez T; Ghattaoraya GS; Martinez JG; Guijarro C; Hardy M; Hollis Z; Hourlier T; Hunt T; Kay M; Kaykala V; Le T; Lemos D; Marques-Coelho D; Marugán JC; Merino GA; Mirabueno LP; Mushtaq A; Hossain SN; Ogeh DN; Sakthivel MP; Parker A; Perry M; Piližota I; Prosovetskaia I; Pérez-Silva JG; Salam AIA; Saraiva-Agostinho N; Schuilenburg H; Sheppard D; Sinha S; Sipos B; Stark W; Steed E; Sukumaran R; Sumathipala D; Suner MM; Surapaneni L; Sutinen K; Szpak M; Tricomi FF; Urbina-Gómez D; Veidenberg A; Walsh TA; Walts B; Wass E; Willhoft N; Allen J; Alvarez-Jarreta J; Chakiachvili M; Flint B; Giorgetti S; Haggerty L; Ilsley GR; Loveland JE; Moore B; Mudge JM; Tate J; Thybert D; Trevanion SJ; Winterbottom A; Frankish A; Hunt SE; Ruffier M; Cunningham F; Dyer S; Finn RD; Howe KL; Harrison PW; Yates AD; Flicek P
Nucleic Acids Res; 2023 Jan; 51(D1):D933-D941. PubMed ID: 36318249
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide screening for differentially methylated long noncoding RNAs identifies LIFR-AS1 as an epigenetically regulated lncRNA that inhibits the progression of colorectal cancer.
Song P; Li Y; Wang F; Pu L; Bao L; Gao H; Zhu C; Wang M; Tao L
Clin Epigenetics; 2022 Oct; 14(1):138. PubMed ID: 36316703
[TBL] [Abstract][Full Text] [Related]
13. Classification and Prognosis Analysis of Pancreatic Cancer Based on DNA Methylation Profile and Clinical Information.
Li X; Zhang X; Lin X; Cai L; Wang Y; Chang Z
Genes (Basel); 2022 Oct; 13(10):. PubMed ID: 36292798
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
